Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stellar specialized in sustainable aquaculture and manufacture of Keyhole Limpet Hemocyanin (KLH), a protein used widely as an immune stimulant and carrier molecule in therapeutic vaccines and diagnostics. Its KLH products have been supplied to multiple biopharma companies developing vaccines for cancer, autoimmune disorders, Alzheimer’s disease, inflammatory diseases, and more. The company did not develop its own therapeutics but enabled others’ pipelines through supply agreements. After merging with Edesa Biotech, focus shifted toward monoclonal antibody therapies targeting inflammatory diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stellar Holdings.